How New U.S. Tariffs Could Reshape Patent Litigation in the Medical Device Industry
As the U.S. imposes sweeping new tariffs on over 180 countries and territories—including a baseline 10% rate and steep increases for China (originally 145%, now reduced to 30% for 90...
Knobbe Martens Partners Outline Major USPTO Policy Shifts in Law360 Article
In a recent Law360 article, Knobbe Martens partners Rosaleen Chou, Ted Cannon, and Philip Nelson highlight significant policy developments at the U.S. Patent and Trademark Office (USPTO) expected to shape...
USPTO Proposes Rule and Director Implements Policy Likely to Limit Multiple Patent Validity Challenges
On Friday, October 17, the USPTO published a proposed rule that, if implemented, would likely reduce filings of inter partes review patent validity challenges. In addition, USPTO Director John Squires...